ZOLMITRIPTAN tablet, film coated United States - English - NLM (National Library of Medicine)

zolmitriptan tablet, film coated

celltrion usa, inc. - zolmitriptan (unii: 2fs66th3yw) (zolmitriptan - unii:2fs66th3yw) - zolmitriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. limitations of use - only use zolmitriptan tablets if a clear diagnosis of migraine has been established. if a patient has no response to zolmitriptan tablets treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan tablets is administered to treat any subsequent attacks. - zolmitriptan tablets is not indicated for the prevention of migraine attacks. - safety and effectiveness of zolmitriptan tablets have not been established for cluster headache. zolmitriptan tablets are contraindicated in patients with: - ischemic coronary artery disease (angina pectoris, history of myocardial infarction, or documented silent ischemia), other significant underlying cardiovascular disease, or coronary artery vasospasm including prinzmetal’s angina [see warnings and precautions (5.1) ] - wolff-parkinson-white syndrome or arrhythmias associated with other cardiac accessory conduction p

Zolmitriptan 2.5 mg Orodispersible Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

zolmitriptan 2.5 mg orodispersible tablets

actavis group ptc ehf - zolmitriptan - orodispersible tablet - 2.5 milligram(s) - selective serotonin (5ht1) agonists; zolmitriptan